Peginterferon Alfa-2a/Ribavirin for 48 or 72 Weeks in Hepatitis C Genotypes 1 and 4 Patients With Slow Virologic Response

2009118 citationsJournal Article

Authors

Good health and well-being

Published in: Gastroenterology

Volume 138, Issue 2, pp. 503-512.e1

Field-Weighted Citation Impact: 10.87